Literature DB >> 1428037

Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.

D N Amarapurkar1, A Kumar, S Vaidya, P Murti, S K Bichile, R H Kalro, H G Desai.   

Abstract

Of forty multi-transfused thalassemia patients (26 males, 14 females; mean age 8.1 +/- 5.3 years, range 1-35) with no clinical or biochemical evidence of liver disease, HBsAg, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies were present in 18 (45%), 7 (17.5%) and 1 (2.5%) cases respectively. Three of the 18 (16.7%) HBsAg positive patients were anti-delta antibody positive. Our results indicate that more than 50% of multi-transfused thalassemia patients show serological evidence of one or more of hepatitis B, C and D and human immunodeficiency virus infection.

Entities:  

Keywords:  Antibodies; Antigen-antibody Reactions; Asia; Biology; Blood Supply; Developing Countries; Diseases; Equipment And Supplies; Examinations And Diagnoses; Hematologic Tests; Hematological Effects; Hemic System; Hepatitis--transmission; Hereditary Diseases; Hiv Infections--transmission; Immunity; Immunologic Factors; India; Laboratory Examinations And Diagnoses; Laboratory Procedures; Physiology; Screening; Southern Asia; Viral Diseases

Mesh:

Substances:

Year:  1992        PMID: 1428037

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  14 in total

Review 1.  Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

Authors:  V P Choudhry; S K Acharya
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

Review 2.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

3.  Transfusion transmitted infections in Indian thalassemics: a perspective.

Authors:  Ajit C Gorakshakar; Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-15       Impact factor: 0.900

Review 4.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

5.  Pathogen reduction of blood bank components: a matter of swings and roundabouts.

Authors:  Albert Farrugia; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2020-08-06       Impact factor: 3.443

6.  A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India.

Authors:  Shrivastava Manisha; Kumar Sanjeev; Navaid Seema; Chotrani Dilip; Dwivedi Rashmi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-12       Impact factor: 0.900

7.  Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major.

Authors:  Aabha Nagral; Smita Sawant; Nishtha Nagral; Pathik Parikh; Priya Malde; Rashid Merchant
Journal:  J Clin Exp Hepatol       Date:  2017-08-23

8.  Hepatitis-G virus infection in multi-transfused patients and intravenous drug abusers: New Delhi experience.

Authors:  Mohammad Asim; Sai Kiran Potukuchi; Ashu Arora; Bhimo Singh; P Kar
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 9.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

10.  Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV, HBV and HCV in India.

Authors:  Susmita Maity; Srijita Nandi; Subrata Biswas; Salil Kumar Sadhukhan; Malay Kumar Saha
Journal:  Virol J       Date:  2012-11-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.